why choose us

First received: December 06, 2022

Clinical Trial: Study of M5049 in DM and PM Participants (NEPTUNIA)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dermatomyositis

Study Type: INTERVENTIONAL


Official Title: A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants Receiving Standard of Care (

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of orally administered M5049 in idiopathic inflammatory myopathies, specifically dermatomyositis (DM) and polymyositis (PM) participants for 24 weeks.

Read more